Targeted Delivery Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4171187
- 99 Pages
- February 2021
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Targeted Delivery Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Targeted Delivery Drugs market segmented into
Ocular Drug Delivery
Pulmonary Drug Delivery
Drug Eluting Stents
Others
Based on the end-use, the global Targeted Delivery Drugs market classified into
Hospital
Clinic
Others
Based on geography, the global Targeted Delivery Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Adverum
Arrowhead Pharmaceuticals
Bayer
Windtree Therapeutics
Immunocore
Mankind Pharma
Roche
Ra Pharma
Keystone Nano
Lipocine
MultiVir
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TARGETED DELIVERY DRUGS INDUSTRY
2.1 Summary about Targeted Delivery Drugs Industry
2.2 Targeted Delivery Drugs Market Trends
2.2.1 Targeted Delivery Drugs Production & Consumption Trends
2.2.2 Targeted Delivery Drugs Demand Structure Trends
2.3 Targeted Delivery Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Ocular Drug Delivery
4.2.2 Pulmonary Drug Delivery
4.2.3 Drug Eluting Stents
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Clinic
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Ocular Drug Delivery
5.2.2 Pulmonary Drug Delivery
5.2.3 Drug Eluting Stents
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Clinic
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Ocular Drug Delivery
6.2.2 Pulmonary Drug Delivery
6.2.3 Drug Eluting Stents
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Clinic
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Ocular Drug Delivery
7.2.2 Pulmonary Drug Delivery
7.2.3 Drug Eluting Stents
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Clinic
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Ocular Drug Delivery
8.2.2 Pulmonary Drug Delivery
8.2.3 Drug Eluting Stents
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Clinic
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Ocular Drug Delivery
9.2.2 Pulmonary Drug Delivery
9.2.3 Drug Eluting Stents
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Clinic
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Adverum
10.1.2 Arrowhead Pharmaceuticals
10.1.3 Bayer
10.1.4 Windtree Therapeutics
10.1.5 Immunocore
10.1.6 Mankind Pharma
10.1.7 Roche
10.1.8 Ra Pharma
10.1.9 Keystone Nano
10.1.10 Lipocine
10.1.11 MultiVir
10.2 Targeted Delivery Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Adverum
10.2.2 Arrowhead Pharmaceuticals
10.2.3 Bayer
10.2.4 Windtree Therapeutics
10.2.5 Immunocore
10.2.6 Mankind Pharma
10.2.7 Roche
10.2.8 Ra Pharma
10.2.9 Keystone Nano
10.2.10 Lipocine
10.2.11 MultiVir
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Targeted Delivery Drugs Product Type Overview
2.Table Targeted Delivery Drugs Product Type Market Share List
3.Table Targeted Delivery Drugs Product Type of Major Players
4.Table Brief Introduction of Adverum
5.Table Brief Introduction of Arrowhead Pharmaceuticals
6.Table Brief Introduction of Bayer
7.Table Brief Introduction of Windtree Therapeutics
8.Table Brief Introduction of Immunocore
9.Table Brief Introduction of Mankind Pharma
10.Table Brief Introduction of Roche
11.Table Brief Introduction of Ra Pharma
12.Table Brief Introduction of Keystone Nano
13.Table Brief Introduction of Lipocine
14.Table Brief Introduction of MultiVir
15.Table Products & Services of Adverum
16.Table Products & Services of Arrowhead Pharmaceuticals
17.Table Products & Services of Bayer
18.Table Products & Services of Windtree Therapeutics
19.Table Products & Services of Immunocore
20.Table Products & Services of Mankind Pharma
21.Table Products & Services of Roche
22.Table Products & Services of Ra Pharma
23.Table Products & Services of Keystone Nano
24.Table Products & Services of Lipocine
25.Table Products & Services of MultiVir
26.Table Market Distribution of Major Players
27.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
28.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
29.Table Global Targeted Delivery Drugs Market Forecast (Million USD) by Region 2021f-2026f
30.Table Global Targeted Delivery Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
31.Table Global Targeted Delivery Drugs Market Forecast (Million USD) by Demand 2021f-2026f
32.Table Global Targeted Delivery Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
